Your browser doesn't support javascript.
loading
To Anticoagulate or Not to Anticoagulate in COVID-19: Lessons after 2 Years.
Rizk, John G; Gupta, Aashish; Lazo, Jose G; Sardar, Partha; Henry, Brandon Michael; Lavie, Carl J; Effron, Mark B.
Afiliação
  • Rizk JG; Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, Maryland.
  • Gupta A; John Ochsner Heart and Vascular Institute, Ochsner Clinical School-The University of Queensland School of Medicine, New Orleans, Louisiana.
  • Lazo JG; UCSF Medical Center, University of California, San Francisco, San Francisco, California.
  • Sardar P; John Ochsner Heart and Vascular Institute, Ochsner Clinical School-The University of Queensland School of Medicine, New Orleans, Louisiana.
  • Henry BM; Cardiac Intensive Care Unit, The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
  • Lavie CJ; Disease Prevention and Intervention & Population Health Programs, Texas Biomedical Research Institute, San Antonio, Texas.
  • Effron MB; John Ochsner Heart and Vascular Institute, Ochsner Clinical School-The University of Queensland School of Medicine, New Orleans, Louisiana.
Semin Thromb Hemost ; 49(1): 62-72, 2023 Feb.
Article em En | MEDLINE | ID: mdl-35468641

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tromboembolia Venosa / COVID-19 Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tromboembolia Venosa / COVID-19 Idioma: En Ano de publicação: 2023 Tipo de documento: Article